DiaMedica Therapeutics
(NASDAQ:DMAC)
$2.32
-0.10[-4.13%]
At close: Apr 24
$2.32
0[0.00%]
After Hours: 4:31PM EDT
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
DMAC

FAQ

Q

How do I buy DiaMedica Therapeutics (DMAC) stock?

A

You can purchase shares of DiaMedica Therapeutics (NASDAQ: DMAC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are DiaMedica Therapeutics's (DMAC) competitors?

A

There are no as such competitors for DiaMedica Therapeutics.

Q

What is the target price for DiaMedica Therapeutics (DMAC) stock?

A

The latest price target for DiaMedica Therapeutics (NASDAQ: DMAC) was reported by Craig-Hallum on Wednesday, April 24, 2024. The analyst firm set a price target for 8.00 expecting DMAC to rise to within 12 months (a possible 244.83% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for DiaMedica Therapeutics (DMAC)?

A

The stock price for DiaMedica Therapeutics (NASDAQ: DMAC) is $2.32 last updated April 24, 2024 at 4:31 PM EDT.

Q

Does DiaMedica Therapeutics (DMAC) pay a dividend?

A

There are no upcoming dividends for DiaMedica Therapeutics.

Q

When is DiaMedica Therapeutics (NASDAQ:DMAC) reporting earnings?

A

DiaMedica Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is DiaMedica Therapeutics (DMAC) going to split?

A

There is no upcoming split for DiaMedica Therapeutics.

Q

What sector and industry does DiaMedica Therapeutics (DMAC) operate in?

A

DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.